Zilebesiran, a potential best-in-disease RNAi anti-hypertensive with twice-yearly subcutaneous dosing, demonstrated encouraging safety when combined with two or more antihypertensives
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Opaganib has shown potential in enhancing ARPI treatment by blocking multiple enzymes involved in cancer cell survival.
BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA population
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
Subscribe To Our Newsletter & Stay Updated
